May 30, 2023 · 40m · neon-show
Joining Deepika to Manage her Investments to Building 82°East with her ft. Jigar K Shah
gold bands on the timeline = statements, start to end. Hover to read, click to jump. CC turns on captions
In this podcast episode, 82°E co-founder Jigar Shah details the journey of building a premium, science-backed skincare brand alongside Bollywood icon Deepika Padukone. He discusses his transition from venture capital investor to operational founder, the mechanics of authentic celebrity partnerships, and the rigorous infrastructure required for global D2C expansion.
How this conversation actually went
Every chapter scored 0–10 on four independent dynamics. Hover any point for the reasoning behind the score. Siddhartha holds 9.7% of the talking time here. How this is scored →
speaking balance: gold is Siddhartha, purple is the guest (3 minute bins)
Jigar directly challenges the assumption that Deepika is not a full-time co-founder, reframing her external activities as essential brand equity inputs.
Hardest push from Siddhartha ▶ 33:42 Challenging fast-failure startup orthodoxySiddhartha challenges the two-year build timeline as running counter to mainstream startup wisdom of moving fast and failing fast.
Biggest teaching moment ▶ 17:30 Detailed three-circle framework for brand ideationJigar delivers a comprehensive lecture on their three-filter Venn diagram framework to show how business white spaces intersect with personal authenticity.
Siddhartha holds their own ▶ 6:05 Pinpointing operator versus investor psychological shiftSiddhartha articulates the core operational heavy challenges an investor turned founder faces when managing basic execution details.
the scores for every segment, with the reasoning behind each
| Chapter | Topic | Siddhartha as informed peer | Guest teaching | Guest disagreement | Siddhartha pushing back | Why |
|---|---|---|---|---|---|---|
| Personal Skincare Routines and Gender-Neutral Care | 3 | 3 | 1 | 1 | Siddhartha starts with casual banter about skincare stereotypes, which Jigar expands upon by referencing consumer research and Shah Rukh Khan breaking gender conventions. | |
| From VC Investor to Hands-On Startup Operator | 4 | 4 | 1 | 1 | Siddhartha notes the shift from high-level investing to operational problem solving, prompting Jigar to detail the psychological and team-building differences. | |
| Mentors and Evolving Celebrity Business Models | 2 | 5 | 2 | 1 | When Nancy suggests Deepika was part of the early wave of celebrity endorsements, Jigar gently corrects the nuance between typical endorsements and structured talent equity deals. | |
| Jigar Shah's Entrepreneurial History and VC Background | 3 | 3 | 1 | 1 | Siddhartha tracks Jigar's career history from his first apparel business to boutique advisory and VC, with Jigar elaborating on the market gaps he identified. | |
| Joining Deepika Padukone's Family Office | 3 | 2 | 0 | 0 | A straightforward recount of how Jigar interviewed with Deepika over Zoom during the lockdown and executed rapid investments for Ka Enterprises. | |
| The Ideation and Product Thesis of 82°East | 3 | 5 | 2 | 1 | When Nancy asks if skincare was predetermined, Jigar outlines their structured Venn diagram framework and explains how Deepika pushed back against purely Ayurvedic positioning. | |
| Co-Founder Dynamics and Division of Roles | 3 | 4 | 2 | 1 | Nancy questions whether a celebrity can truly be full-time; Jigar reframes the definition of founder commitment around impact and strict division of creative versus business responsibilities. | |
| Founder Pitfalls and Brand Benchmark Aspirations | 2 | 4 | 1 | 0 | Jigar shares founder lessons on avoiding product romanticization, differentiating between painkillers and vitamins, and building benchmark brands. | |
| Rapid-Fire Insights and Founding Timeline | 3 | 3 | 1 | 1 | Siddhartha conducts a rapid-fire questioning round touching on Deepika's intuitive business grasp and the origin timeline of 82°East. | |
| Rigorous Product Testing and Global Supply Chain Tech | 4 | 4 | 1 | 1 | Siddhartha prompts on counterintuitive D2C development cycles, leading Jigar to explain clinical testing regimens, supply chain tech, and premium pricing dynamics. |